Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Clinical trial NCT02673814 · WITHDRAWN
Trial details
- NCT number
- NCT02673814
- Sponsor
- Peregrine Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.